Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
about
Wholegrain cereals for coronary heart diseaseLow glycaemic index diets for coronary heart diseaseLow glycaemic index diets for coronary heart diseaseVisceral adiposity syndromeHerbal Medicines for Treating Metabolic Syndrome: A Systematic Review of Randomized Controlled TrialsAndrogen deprivation therapy and cardiovascular disease: what is the linking mechanism?Fetal programming and early identification of newborns at high risk of free radical-mediated diseasesNeuroinflammatory basis of metabolic syndromeSodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effectsMetabolic and cardiovascular complications in the liver transplant recipientEffects of exercise and diet on chronic diseaseRelationships between inflammation, adiponectin, and oxidative stress in metabolic syndromeCross-sectional study of diet, physical activity, television viewing and sleep duration in 233,110 adults from the UK Biobank; the behavioural phenotype of cardiovascular disease and type 2 diabetesCardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR.Ameliorative potential of Coccinia grandis extract on serum and liver marker enzymes and lipid profile in streptozotocin induced diabetic rats.Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study.Phenotypic, genetic, and genome-wide structure in the metabolic syndromeCoronary artery disease and arterial hypertension: clinical, angiographic and follow-up data.The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.Focal Adhesion Kinase contributes to insulin-induced actin reorganization into a mesh harboring Glucose transporter-4 in insulin resistant skeletal muscle cellsElevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study.Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up studyPrevalence of metabolic syndrome and related factors in bank employees according to different defining criteria, Vitória/ES, BrazilWeight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort.Factor analysis of metabolic syndrome components in the Coronary Artery Risk Development in Young Adults (CARDIA) study: examination of factors by race-sex groups and across time.Association of the apolipoprotein b/apolipoprotein a-I ratio, metabolic syndrome components, total cholesterol, and low-density lipoprotein cholesterol with insulin resistance in the population of georgia.Vitamin D status is inversely associated with markers of risk for type 2 diabetes: A population based study in Victoria, Australia.The metabolic syndrome X.Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Sugar-sweetened beverages and prevalence of the metabolically abnormal phenotype in the Framingham Heart Study.The long term health consequences of polycystic ovary syndrome.Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional studyHeritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.Metabolic normality in overweight and obese subjects. Which parameters? Which risks?Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction.Insulin resistance: an independent risk factor for cardiovascular disease?
P2860
Q24245465-71323C39-542A-4BD5-AA85-77074AAE06A5Q24245788-7D608CB4-0E43-4532-83B1-A5ECF2BEA4D7Q24248126-C460C032-8CB8-424C-BEEE-CE956FE2F475Q26738890-01028A29-99EF-4910-B1B2-A2D240452CEBQ26740415-D2A8BB0C-62EF-4A6A-B54D-8858111F944BQ26749088-557D1512-D29A-4CA7-893B-BFE9685F72A6Q26750488-63024FF2-0C6D-4E61-A28D-BF3D94047184Q26852584-4872C51A-F5A9-4EAC-B248-F1219D3B3E81Q28072765-33404CC4-62C1-4588-93FE-90B484ABF00EQ28082243-AB69444A-7DF2-4264-B4B3-1C4218AA2129Q28297798-265C79E0-1D5B-4C2F-BA9A-627FF9085E61Q28483891-0B200824-0D30-4B78-B826-20C40A2979E8Q28602371-DBF4C506-F77B-468E-8A15-CF226F656D30Q30303166-45D71E92-3792-4FD8-A7E1-FDDFF90E6F5AQ30418585-36BF0BAF-8634-4EC4-B26E-903449337FB4Q30440409-E2865284-6704-45F9-B234-D3A1566CDFE9Q31049211-6D0E3EC3-A888-434C-93D5-F7B0ADC3FCE7Q31537492-FA89240A-3A0B-419C-AD26-4120235342A9Q33359617-DB031032-DC7A-441C-87C6-490C9DEEE4C4Q33366859-DEB64463-C32C-46F8-B523-6BE12D8863BBQ33374940-3C287B0D-5CB4-451F-A34F-F74DBE1155A0Q33380194-28B6AC39-E304-4024-978C-461123C16388Q33444359-C754DF07-DDB3-4A49-9F3A-26DA47986987Q33455432-956DC2F5-A7BD-4EC2-A10E-5B622E15BAEDQ33651745-16C67C08-79D1-4996-819B-74626078A283Q33665195-01E55171-5F68-4A32-AE9D-916F2A5BB602Q33739964-524B10E1-2423-4B7A-93B9-408F979170AFQ33757938-82277602-7687-4E8D-A71C-0E9FA59610D7Q33936947-A5E34823-18E5-40B8-9758-DDB1954F724AQ33936953-13EA46E7-6D91-425E-9FBE-17EF58504306Q34031701-C79EB5C6-7EA0-4E83-8A6D-F230CD8706C0Q34071040-529AE8CC-973E-4C13-B481-7EEB7B5379A7Q34105196-9F1335DF-352B-448E-8F97-6303825149A7Q34110733-2BC53C8A-23DA-446C-8393-37BBC7C95438Q34146740-D499F988-2F0D-4F6F-A697-3D0C7708BC71Q34147834-72DDD13F-5BFB-4E74-BFB7-5D57D025CE34Q34157549-D128990C-E92B-4A33-80E4-D6F19F735B79Q34159256-02CDA400-B19C-45D9-A6A8-91B420975583Q34159728-0C8487BB-0C09-47E0-A79D-2C6053CBBA67Q34163104-EEF77A5D-B929-4797-B02C-D267A9954148
P2860
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
@en
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
@nl
type
label
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
@en
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
@nl
prefLabel
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
@en
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
@nl
P2093
P356
P1433
P1476
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
@en
P2093
E Ferrannini
S M Haffner
P2888
P304
P356
10.1007/BF00403180
P577
1991-06-01T00:00:00Z